<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Xuan Phong Pham</style></author><author><style face="normal" font="default" size="100%">Tran Thi Tuyet Nhung</style></author><author><style face="normal" font="default" size="100%">Hoai Nam Trinh</style></author><author><style face="normal" font="default" size="100%">Do Minh Trung</style></author><author><style face="normal" font="default" size="100%">Dang Truong Giang</style></author><author><style face="normal" font="default" size="100%">Binh Duong Vu</style></author><author><style face="normal" font="default" size="100%">Nguyen Trọng Diep</style></author><author><style face="normal" font="default" size="100%">Nguyen Van Long</style></author><author><style face="normal" font="default" size="100%">Van Thu Nguyen</style></author><author><style face="normal" font="default" size="100%">Chu Van Men</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Isolation and Structural Characterization of Compounds from Blumea lacera</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Asteraceae</style></keyword><keyword><style  face="normal" font="default" size="100%">Blumea lacera</style></keyword><keyword><style  face="normal" font="default" size="100%">Column chromatography</style></keyword><keyword><style  face="normal" font="default" size="100%">Flavonoid</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">July 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">999-1004</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;The medicinal plants consider as a rich resource of ingredients which can be used in drug development and synthesis. Blumea lacera (Burm. f.) DC. is generally used in traditional medicine for the treatment of cough, bronchitis, dysentery, wound healing. The aim of this study is to isolate and identify the compounds from the aerial parts of Blumea lacera. &lt;strong&gt;Methods:&lt;/strong&gt; The aerial parts of B. lacera were dried, powdered and extracted using EtOH, and the concentrated extract was partitioned in succession with n-hexane, CH&lt;sub&gt;2&lt;/sub&gt;Cl&lt;sub&gt;2&lt;/sub&gt;, and EtOAc. From the EtOAc fraction, the compounds were isolated through column chromatography and their chemical structures were elucidated by NMR spectroscopy and confirmed by comparison of their NMR data with literature data. &lt;strong&gt;Results:&lt;/strong&gt; Repeated column chromatography of the EtOAc-soluble fraction from the aerial parts of B. lacera resulted in the isolation of β-sitosterol (1), campesterol (2), artemetin (3) and acid paracatechuic (4).&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">999</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Xuan Phong Pham&lt;sup&gt;1,&lt;/sup&gt;#, Tran Thi Tuyet Nhung&lt;sup&gt;1,&lt;/sup&gt;#, Hoai Nam Trinh&lt;sup&gt;1&lt;/sup&gt;, Do Minh Trung&lt;sup&gt;4&lt;/sup&gt;, Dang Truong Giang&lt;sup&gt;2&lt;/sup&gt;, Binh Duong Vu&lt;sup&gt;2&lt;/sup&gt;, Nguyen Trọng Diep&lt;sup&gt;3&lt;/sup&gt;, Nguyen Van Long&lt;sup&gt;3&lt;/sup&gt;, Van Thu Nguyen&lt;sup&gt;3,&lt;/sup&gt;*, Chu Van Men&lt;sup&gt;4,&lt;/sup&gt;*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Military Institute of Traditional Medicine, 442 Kim Giang, Hoang Mai, Ha Noi, VIETNAM.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;The Drug R&amp;amp;D Center, Vietnam Military Medical University, 160 Phung Hung, Ha Dong, Hanoi, VIETNAM.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Institute of Pharmaceutical Education, Vietnam Military Medical University, 160 Phung Hung, Ha Dong, Hanoi, VIETNAM.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Institute of Biomedicine and Pharmacy, Vietnam Military Medical University, 160 Phung Hung, Ha Dong, Hanoi, VIETNAM.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nguyen Van Long</style></author><author><style face="normal" font="default" size="100%">Chu Van Men</style></author><author><style face="normal" font="default" size="100%">Anh Vu Tuan</style></author><author><style face="normal" font="default" size="100%">Nguyen Van Manh</style></author><author><style face="normal" font="default" size="100%">Thanh Chu Duc</style></author><author><style face="normal" font="default" size="100%">Ha Bui Thi Thu</style></author><author><style face="normal" font="default" size="100%">Hoang Van Luong</style></author><author><style face="normal" font="default" size="100%">Le Bach Quang</style></author><author><style face="normal" font="default" size="100%">Pham Gia Khanh</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">A New LC/MS/MS Method for the Analysis of Phyllanthin in Rat Plasma and its Application on Comparative Bioavailability of Phyllanthin in Different Formulations after Oral Administration in Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">LC-MS/MS</style></keyword><keyword><style  face="normal" font="default" size="100%">Pharmacokinetics</style></keyword><keyword><style  face="normal" font="default" size="100%">Phospholipid</style></keyword><keyword><style  face="normal" font="default" size="100%">Phyllanthin</style></keyword><keyword><style  face="normal" font="default" size="100%">Plasma</style></keyword><keyword><style  face="normal" font="default" size="100%">Quantitation</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">968-975</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;A simple, short UPLC/MS/MS method for quantitation of phyllanthin in rat plasma in less than 2 minutes have been developed and fully validated. The validated method was used to investigate the pharmacokinetic properties of phyllanthin in PA extract and phospholipid complex of PA extract in rat. &lt;strong&gt;Methods:&lt;/strong&gt; The separation was carried out on Acquity C&lt;sub&gt;18 &lt;/sub&gt;(50 x 2.1 mm; 1.7 μm), with a mobile phase of 10 mM aqueous amonium acetate and acetonitrile (10:90; v/v), at a flow rate of 0.2 mL/min. Felodipin was used as internal standard. Phyllanthin is extracted from a small volume of rat plasma (100 μl) by means of liquid-liquid extraction method with tert butyl methyl ether. Electrospray ionization (ESI) mass spectrometry was applied in positive mode at capillary voltage of 4000 V for both phyllanthin and IS, cone voltage of 24 V for phyllanthin and 20 V for IS, desolvation temperature of 360oC, cone gas flow of 25 L/h, collision energy of 12 V for phyllanthin and 10 V for IS. Multiple reaction monitoring (MRM) was used to monitor the transitions at m/z (Q1/Q3) 436.41/355.36 for phyllanthin and 384.20/352.18 for IS. &lt;strong&gt;Results:&lt;/strong&gt; The linear calibration curve of phyllanthin was obtained over the concentration range of 0.5 – 100 ng/mL. The intra‐ and inter‐day precisions were less than 7.08 % and the accuracies were within ± 7.55%. The Cmax values of phyllanthin from two different preparations in rat plasma after oral administration of 2.0 mg/kg were 11.44 and 31.44 ng/ml, and the AUC values were 18.07 and 41.43 h.ng/ml, respectively. &lt;strong&gt;Conclusion:&lt;/strong&gt; A simple, short UPLC/MS/MS method for quantitation of phyllanthin in rat plasma in less than 2 minutes have been developed and fully validated. The bioavailability of phyllanthin from the phospholipid complex of PA extract in rat plasma was significantly improved compared with that of raw PA extract after oral administration.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">968</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Nguyen Van Long&lt;sup&gt;#&lt;/sup&gt;, Chu Van Men&lt;sup&gt;#,&lt;/sup&gt;*, Anh Vu Tuan, Nguyen Van Manh, Thanh Chu Duc, Ha Bui Thi Thu, Hoang Van Luong, Le Bach Quang, Pham Gia Khanh&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;nstitute of Biomedicine and Pharmacy, Vietnam Military Medical University, 222-Phung Hung Street, Ha Dong District, Hanoi, VIETNAM.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;#&lt;/sup&gt;These authors contributed equally to this work&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nguyen Van Long</style></author><author><style face="normal" font="default" size="100%">Bui Thi Thu Ha</style></author><author><style face="normal" font="default" size="100%">Anh Vu Tuan</style></author><author><style face="normal" font="default" size="100%">Hoang Van Luong</style></author><author><style face="normal" font="default" size="100%">Nguyen Tung Linh</style></author><author><style face="normal" font="default" size="100%">Thanh Chu Duc</style></author><author><style face="normal" font="default" size="100%">Phung Cao Dai</style></author><author><style face="normal" font="default" size="100%">Chul Soon Yong</style></author><author><style face="normal" font="default" size="100%">Chu Van Men</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Phytosomal Nanoparticles Preparation of Curcuminoids to Enhance Cellular Uptake of Curcuminoids on Breast Cancer Cell Line MCF-7</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cellular uptake</style></keyword><keyword><style  face="normal" font="default" size="100%">Curcuminoids</style></keyword><keyword><style  face="normal" font="default" size="100%">FACS analysis</style></keyword><keyword><style  face="normal" font="default" size="100%">Nanoparticle</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytosome</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">1037-1045</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Curcuminoids, the bioactive compounds extracted from &lt;em&gt;Curcuma longa &lt;/em&gt;consisting of Curcumin (CUR), demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC), have shown promising biological effects, including anticancer activity. This study sought to prepare a physically stable phytosomal nanoparticles of curcuminoids (Curs-Phyto) to facilitate uptake of curcuminoids on breast cancer cells line, and further increase the cytotoxicity against cancer cells. &lt;strong&gt;Methods: &lt;/strong&gt;The evaporation combined extrusion technique was employed to prepare phytosomal curcuminoids nanoparticles. The interaction between curcuminoids and phospholipid by a hydrogen bond was confirmed by differential scanning calorimetry (DSC), powder X-ray diffraction (XRD), fourier transform infrared (FT-IR), and &lt;sup&gt;1&lt;/sup&gt;H nuclear magnetic resonance (&lt;sup&gt;1&lt;/sup&gt;H-NMR). Their physicochemical characterizations and stability in simulated gastric and intestinal media were investigated. The effects of Curs-Phyto on MCF-7 cells were evaluated by flow cytometry, MTS assay and cell cycle analysis. &lt;strong&gt;Results:&lt;/strong&gt; We found that the Curs-Phyto were formed at a spherical shape with good size (~ 180 nm), a narrow size distribution (PDI &amp;lt; d0.2), high complexation rate (~ 87%, 95%, and 90% for BDMC, DMC, and CUR respectively) and high loading capacity of curcuminoids. More importantly, the Curs-Phyto showed the increased cellular uptake and enhanced cytotoxicity against MCF- 7 cancer cells, compared to free curcuminoids. &lt;strong&gt;Conclusion: &lt;/strong&gt;These results indicated that the phytosome could be a promising oral delivery system for curcuminoids for cancer treatment.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1037</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Nguyen Van Long&lt;sup&gt;1,#&lt;/sup&gt;, Bui Thi Thu Ha&lt;sup&gt;1,#&lt;/sup&gt;, Anh Vu Tuan&lt;sup&gt;1&lt;/sup&gt;, Hoang Van Luong&lt;sup&gt;1&lt;/sup&gt;, Nguyen Tung Linh&lt;sup&gt;1&lt;/sup&gt;, Thanh Chu Duc&lt;sup&gt;1&lt;/sup&gt;, Phung Cao Dai&lt;sup&gt;2&lt;/sup&gt;, Chul Soon Yong&lt;sup&gt;2&lt;/sup&gt;, Chu Van Men&lt;sup&gt;1,#&lt;/sup&gt;,* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Institute of Biomedicine and Pharmacy, Vietnam Military Medical University, 222-Phung Hung Street, Ha Dong District, Hanoi, VIETNAM.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Laboratory of Pharmaceutics, College of Pharmacy, Yeungnam University, 214-1 Dae-Dong, Gyeongsan 712-749, REPUBLIC OF KOREA. #These authors contributed equally to this work.&lt;/p&gt;
</style></auth-address></record></records></xml>